Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-10-09

Clinical Trial Update: Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer

View source ↗

Summary

This clinical trial investigating early lung cancer cells in malignant pleural effusion samples from patients with primary lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Lung Cancer, Metastatic Cancer | Status: WITHDRAWN